We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A New York healthcare network is studying famotidine, the active ingredient in the heartburn drug Pepcid, as a potential treatment for COVID-19. Read More
Sanofi and Regeneron have modified their clinical trial of the rheumatoid arthritis drug Kevzara (sarilumab) as a COVID-19 treatment after preliminary results found no benefit in one group. Read More
In a letter to the FDA last week, 35 federal lawmakers recommend the agency consider approving human “challenge” trials for COVID-19, which would infect healthy volunteers with the deadly virus to test efficacy of a vaccine. But the FDA and some researchers have expressed concern over the ethics involved. Read More